2009 - 2012  CQAB149B2348  A phase IIIb multicenter, 52 week treatment, randomized, blinded, double dummy, parallel group efficacy study comparing the effect of inhaled indacaterol 150 rg o.d. vs inhaled tiotropium 18 rg o.d. on lung function, rate of exacerbations and related outcomes in patients with COPD
2014 - 2015  CCD-1207-PR-0091   A 52-Week, Double Blind, Randomized, Multinational, Multicentre, 2-Arm Parallel Group, Active Controlled Clinical Trial Of Fixed Combination Of Beclometasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrrolate Bromide Administered Via pMDI (CHF 5993) Versus Fixed Combination Of Beclometasone Dipropionate Plus Formoterol Fumarate Administered Via pMDI In Patients With Chronic Obstructive Pulmonary Disease” as amended from time to time and incorporated herein by reference
2014 - 2015  201314  A randomized, parallel group study to evaluate the effect of Umeclidinium (UMEC) added to Inhaled corticosteroid/ longacting beta-agonist combination therapy in subjects with Chronic Obstructive Pulmonary Disease COPD